The mitochondrial stress-induced synaptic damage was associated with the oxidative stress-mediated activation of p38 MAPK, and treatment with a p38 MAPK inhibitor improved neurogenesis and increased the expression levels of synaptophysin and PSD-95 in cybrids derived from a patient with Alzheimer’s disease [45]. The gene discussed is DLG4; the disease is Alzheimer disease.